Today 23 rd October 2024, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has licensed a second drug that can slow down Alzheimer’s disease, called donanemab. This means that the ...

Any Australian who has filled a prescription at the chemist will have been asked if they want a branded product or the generic version. And with consumers looking to cut costs wherever they can ...

When Adobe Premiere Pro shows the error “The importer reported a generic error” it usually happens when trying to import media files. This error often means ...

As a host of generics circle the gates, Novartis has lost another bid to waylay MSN Pharmaceuticals’ copycat of the Swiss pharma’s top-selling drug Entresto. In a court decision filed this ...

Drugs such as Novo Nordisk’s blockbuster Ozempic can cut drug and alcohol abuse by up to 50% according to a new study, adding to mounting evidence that the drugs yield health benefits beyond ...

Lundbeck, a global drugmaker based in Denmark, has agreed to buy La Jolla-based Longboard Pharmaceuticals for $2.6 billion to gain access to its novel epilepsy drug. The acquisition announced ...

The Indian Patent Office has rejected Viiv Healthcare's patent application for the HIV drug, dolutegravir, after nearly a decade of legal battles. This decision opens the market for generic ...

Now, a drug called naltrexone – referred to as ‘Ozempic for drinkers’ – has gone viral on social media, and being praised for helping those struggling with alcohol overconsumption to cut down.

The drug is part of a new generation of treatments that are reaching market, substantially expanding the options patients with the condition have. Roche’s Hemlibra has become a new preventive standard ...

Oct. 14, 2024 – A new breast cancer drug has received quick federal approval after a clinical trial showed it could more than double the time before a common type of breast cancer recurrence ...

Oct 11 (Reuters) - The U.S. Food and Drug Administration approved Pfizer's (PFE.N), opens new tab once-a-week injection for the two main types of a rare bleeding disorder called hemophilia ...

Zydus Lifesciences has received the USFDA's final approval to produce a generic version of Paliperidone extended-release tablets, which are used to treat schizophrenia and schizoaffective disorders.